An overview of mineralocorticoid receptor antagonists as a treatment option for patients with heart failure: the current state-of-the-art and future outlook-Reference-Cited by-同舟云学术

An overview of mineralocorticoid receptor antagonists as a treatment option for patients with heart failure: the current state-of-the-art and future outlook

Published:2022-10-13 Issue:15 Volume:23 Page:1737-1751
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Lorente-Ros Marta¹^ORCID,Aguilar-Gallardo Jose S¹,Shah Aayush²,Narasimhan Bharat²,Aronow Wilbert S.³

Affiliation:

1. Department of Medicine, The Icahn School of Medicine at Mount Sinai, New York, NY, USA

2. DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA

3. Department of Cardiology, New York Medical College, Westchester Medical Center, Valhalla, NY, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2138744

Reference116 articles.

1. Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases

2. The Role of the Mineralocorticoid Receptor and Mineralocorticoid Receptor–Directed Therapies in Heart Failure

3. Mineralocorticoid Receptors

4. The Multifaceted Mineralocorticoid Receptor

5. Aldosterone: Cardiovascular assault

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence for the druggability of aldosterone targets in heart failure: A bioinformatics and data science-driven decision-making approach;Computers in Biology and Medicine;2024-03

2. Overview of the safety, efficiency, and potential mechanisms of finerenone for diabetic kidney diseases;Frontiers in Endocrinology;2023-12-20

3. Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials;Heart Failure Reviews;2023-08-10

4. Research Progress in Finerenone in Cardiovascular Diseases;Cardiovascular Innovations and Applications;2023